No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose We evaluated the effect of positive superficial and/or deep margin status on local recurrence (LR) in invasive breast cancer treated with breast-conserving surgery (BCS) followed by radiotherapy. Materials and Methods In total, 3,403 stage 1 and 2 invasive breast cancer patients treated with BCS followed by radiotherapy from January 2000 to December 2008 were included in this study. These patients were divided into three groups according to margin status: clear resection margin status for all sections (group 1, n=3,195); positive margin status in superficial and/or deep sections (group 2, n=121); and positive peripheral parenchymal margin regardless of superficial and/or deep margin involvement (group 3, n=87). The LR-free survival between these three groups was compared and the prognostic role of margin status was analyzed. Results Across all groups, age, tumor size, nodal status, and human epidermal growth factor receptor 2 status did not significantly differ. High grade, positive extensive intraductal component, hormone receptor positivity, hormone therapy received, and chemotherapy not received were more prevalent in groups 2 and 3 than in group 1. Five-year LR rates in groups 1, 2, and 3 were 1.9%, 1.7%, and 7.7%, respectively. Multivariate analysis revealed that group 3 was a significant predictor for LR (hazard ratio [HR], 4.78; p < 0.001), but that positive superficial and/or deep margin was not (HR, 0.66; p=0.57). Conclusion Superficial and/or deep margin involvement following BCS is not an important predictor for LR.
Abstract
Purpose We evaluated the effect of positive superficial and/or deep margin status on local recurrence (LR) in invasive breast cancer treated with breast-conserving surgery (BCS) followed by radiotherapy. Materials and Methods In total, 3,403 stage 1 and 2 invasive breast cancer patients treated with BCS followed by radiotherapy from January 2000 to December 2008 were included in this study. These patients were divided into three groups according to margin status: clear resection margin status for all sections (group 1, n=3,195); positive margin status in superficial and/or deep sections (group 2, n=121); and positive peripheral parenchymal margin regardless of superficial and/or deep margin involvement (group 3, n=87). The LR-free survival between these three groups was compared and the prognostic role of margin status was analyzed. Results Across all groups, age, tumor size, nodal status, and human epidermal growth factor receptor 2 status did not significantly differ. High grade, positive extensive intraductal component, hormone receptor positivity, hormone therapy received, and chemotherapy not received were more prevalent in groups 2 and 3 than in group 1. Five-year LR rates in groups 1, 2, and 3 were 1.9%, 1.7%, and 7.7%, respectively. Multivariate analysis revealed that group 3 was a significant predictor for LR (hazard ratio [HR], 4.78; p < 0.001), but that positive superficial and/or deep margin was not (HR, 0.66; p=0.57). Conclusion Superficial and/or deep margin involvement following BCS is not an important predictor for LR.
참고문헌 (28)
- Forrest AP, "Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group", Lancet, 348, pp.708~713 (1996)[DOI]
- Malmstrom P, "Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening", Eur J Cancer, 39, pp.1690~1697 (2003)[DOI]
- 고범석, "Changing Patterns in the Clinical Characteristics of Korean Breast Cancer from 1996-2010 Using an Online Nationwide Breast Cancer Database", Journal of Breast Cancer, 15(4), pp.393~400 (2012), 한국유방암학회[DOI]
- Clarke M, "Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials", Lancet, 366, pp.2087~2106 (2005)[DOI]
- Houssami N, "Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy", Eur J Cancer, 46, pp.3219~3232 (2010)[DOI]
- Singletary SE, "Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy", Am J Surg, 184, pp.383~393 (2002)[DOI]
- Coates AS, "Tailoring therapies: improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015", Ann Oncol, 26, pp.1533~1546 (2015)[DOI]
- NIH consensus conference, "Treatment of early-stage breast cancer", JAMA, 265, pp.391~395 (1991)[DOI]
- McIntosh A, "Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer", Am J Clin Oncol, 30, pp.146~151 (2007)[DOI]
- Fisher ER, "Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity", Cancer, 57, pp.1717~1724 (1986)[DOI]
- Veronesi U, "Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial", Ann Oncol, 12, pp.997~1003 (2001)[DOI]
- Lupe K, "Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy", Int J Radiat Oncol Biol Phys, 81, pp.e561~e568 (2011)[DOI]
- Heimann R, "Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience", Cancer, 78, pp.1722~1730 (1996)[DOI]
- Moran MS, "Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer", Ann Surg Oncol, 21, pp.704~716 (2014)[DOI]
- Cellini C, "Factors associated with residual breast cancer after re-excision for close or positive margins", Ann Surg Oncol, 11, pp.915~920 (2004)[DOI]
- Mullen R, "Involved anterior margins after breast conserving surgery: is re-excision required?", Eur J Surg Oncol, 38, pp.302~306 (2012)[DOI]
- Losken A, "A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique", Ann Plast Surg, 72, pp.145~149 (2014)[DOI]
- De Lorenzi F, "Oncological results of oncoplastic breastconserving surgery: Long term follow-up of a large series at a single institution: A matched-cohort analysis", Eur J Surg Oncol, 42, pp.71~77 (2016)[DOI]
- Tenofsky PL, "Surgical, oncologic, and cosmetic differences between oncoplastic and nononcoplastic breast conserving surgery in breast cancer patients", Am J Surg, 207, pp.398~402 (2014)[DOI]
- Chakravorty A, "How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery", Eur J Surg Oncol, 38, pp.395~398 (2012)[DOI]
- Kaur N, "Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer", Ann Surg Oncol, 12, pp.539~545 (2005)[DOI]
- de Bock GH, "Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies", Eur J Cancer, 42, pp.351~356 (2006)[DOI]
- Bulent Koca, "Factors affecting surgical margin positivity in invasive ductal breast cancer patients who underwent breast-conserving surgery after preoperative core biopsy diagnosis", Annals of Surgical Treatment and Research, 84(3), pp.154~159 (2013), 대한외과학회
- Schnitt SJ, "Processing and evaluation of breast excision specimens: a clinically oriented approach", Am J Clin Pathol, 98, pp.125~137 (1992)[DOI]
- Cabioglu N, "Role for intraoperative margin assessment in patients undergoing breast-conserving surgery", Ann Surg Oncol, 14, pp.1458~1471 (2007)[DOI]
- Gabos Z, "The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer", Breast Cancer Res Treat, 124, pp.187~194 (2010)[DOI]
- Foulkes WD, "Triple-negative breast cancer", N Engl J Med, 363, pp.1938~1948 (2010)[DOI]
- Lowery AJ, "Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype", Breast Cancer Res Treat, 133, pp.831~841 (2012)[DOI]
